IRCT2016050427745N1已完成2 期
Preventive effect of lycopene on cisplatin nephrotoxicity in cancer patient
Vice chancellor for research, Shahrekord university of medical sciences0 个研究点目标入组 120 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20 years 至 80 years（—）
- 性别
- All
入选标准
- •The inclusion criteria were condidered to be suffering cancer without primary involvement or renal metastasis; being candidate for administration of 70-100 mg/m2 cisplatin; being 20-80 years old; Cr < 1.5; normal hearing; no underlying nephropathy; ; performance status of 0-2.
- •Exclusion criteria were death; allergy to lycopene; hearing loss; moderate to severe neuropathy; renal metastatic involvement.
排除标准
- 未提供
研究者
相似试验
招募中
3 期
ycopene nephroprotective effect in patients receiving vancomyciIRCT20171030037093N37Esfahan University of Medical Sciences60
进行中（未招募）
不适用
Aprepitant in the prevention of cisplatin-induced delayed emesis: a double-blind randomized study - Aprepitant for cisplatin-induced delayed emesisEUCTR2008-001339-37-ITAZIENDA OSPEDALIERA S. MARIA DI TERNI560
招募中
2 期
Effect of lycopene chaperoned with phosphatidylcholine on progression and outcomes of nonalcoholic steatohepatitis.ACTRN12615000386538ycotec Ltd, Cambridge, UK80
已完成
不适用
Effects of Cimetidine on Cisplatin-induced NephrotoxicityHead and Neck cancer10027655NL-OMON35018Erasmus MC, Universitair Medisch Centrum Rotterdam20
尚未招募
3 期
Curcumin in the prevention of cisplatin-induced acute nephrotoxicityephrotoxicity.Other acute kidney failureN17.8IRCT20180722040556N8Esfahan University of Medical Sciences100